Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 453

ScaleIO stores $12m

Amnon Bar-Lev, the president of network security software company Check Point Software Technologies joins affiliate fund of Greylock Ventures, Greylock Israel Partners, and Norwest Venture participating in a $12m first round of funding for software design storage company ScaleIO.

Dec 17, 2012

Medtronic flexes way into MC10 round

Medtronic is one of two strategic investors backing MC10's technology, which makes it is easier to twist, stretch and expand integrated circuits, which can be used inside or on the human body.

Dec 17, 2012

Lundbeckfond, SR One lead River Vision A round

Lundbeckfond Ventures and SR one co-lead a $17m Series A round into US-based River Vision Development Corp, a company managed under contract with Narrow River for developing the drug RV001

Dec 16, 2012

Cerapedics grafts for $19m

MedImmune Ventures and CVF co-lead a $19m Series C into US-based medical device company Cerapedics.

Dec 16, 2012

Cerulean raises $13m

US-based Cerulean Pharma, a nanopharmaceutical company backed by Lilly Ventures, raises $13m from a consortium of previous backers, bringing the total raised by the drug company to $80m.

Dec 14, 2012

HelloFresh cooks up $10m

Vorwerk Ventures participates in a $10m round of funding for UK-based recipe subscription service HelloFresh.

Dec 12, 2012

Novartis treats Galera

Novartis, via its Novartis Venture Funds, participates in a $11m Series A round for cancer treatment company Galera Therapeutics.

Dec 12, 2012

Epic Sciences receives an injection of $13m

US-based Epic Sciences, a biotech and cancer diagnostics company, raises $13m in Series B financing.

Dec 9, 2012

BioMerieux purchases Quanterix stake

US-based Quanterix, a maker of diagnostic tests, closes its Series C round at $18.5m, a round which included a $15m equity stake from multinational biotechnology company BioMerieux.

Dec 6, 2012

Morgan Stanley leads Nanostring E round

US-based financial services firm Morgan Stanley has led a $15.3m Series E round for US-based NanoString Technologies, a spin out of Seattle-based Institute for Systems Biology.

Dec 6, 2012
© 2026 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here